Ubs Group Ag Alpha Tau Medical Ltd. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 33,019 shares of DRTS stock, worth $99,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,019
Previous 70
47070.0%
Holding current value
$99,057
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.59MCall Options Held
0Put Options Held
0-
Hoyle Cohen, LLC269KShares$807,2640.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$692,1120.0% of portfolio
-
Kovitz Investment Group Partners, LLC226KShares$678,9600.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY223KShares$667,5420.06% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$198,9780.01% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $207M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...